241 related articles for article (PubMed ID: 11814237)
1. Lactoferrin stimulates killing and clearance of bacteria but does not prevent mortality of diabetic mice.
Zagulski T; Jarzabek Z; Zagulska A; Jaszczak M; Kochanowska IE; Zimecki M
Arch Immunol Ther Exp (Warsz); 2001; 49(6):431-8. PubMed ID: 11814237
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin increases both resistance to Salmonella typhimurium infection and the production of antibodies in mice.
Drago-Serrano ME; Rivera-Aguilar V; Reséndiz-Albor AA; Campos-Rodríguez R
Immunol Lett; 2010 Nov; 134(1):35-46. PubMed ID: 20727369
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial system generated by lactoferrin in mice in vivo is primarily a killing system.
Zagulski T; Lipiński P; Zagulska A; Jarzabek Z
Int J Exp Pathol; 1998 Apr; 79(2):117-23. PubMed ID: 9709381
[TBL] [Abstract][Full Text] [Related]
4. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
Artym J; Zimecki M; Kruzel ML
Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin inhibits the effector phase of the delayed type hypersensitivity to sheep erythrocytes and inflammatory reactions to M. bovis (BCG).
Zimecki M; Machnicki M
Arch Immunol Ther Exp (Warsz); 1994; 42(3):171-7. PubMed ID: 7487348
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection.
Flores-Villaseñor H; Canizalez-Román A; Velazquez-Roman J; Nazmi K; Bolscher JG; Leon-Sicairos N
Biochem Cell Biol; 2012 Jun; 90(3):405-11. PubMed ID: 22332993
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils.
Zimecki M; Artym J; Chodaczek G; Kocieba M; Kruzel ML
Inflamm Res; 2004 Jul; 53(7):292-6. PubMed ID: 15241563
[TBL] [Abstract][Full Text] [Related]
8. Bovine lactoferrin: benefits and mechanism of action against infections.
Yamauchi K; Wakabayashi H; Shin K; Takase M
Biochem Cell Biol; 2006 Jun; 84(3):291-6. PubMed ID: 16936799
[TBL] [Abstract][Full Text] [Related]
9. Lethality in LPS-induced endotoxemia in C3H/HeCr mice is associated with prevalence of proinflammatory cytokines: lack of protective action of lactoferrin.
Zimecki M; Chodaczek G; Kocieba M; Kruzel ML
FEMS Immunol Med Microbiol; 2004 Oct; 42(2):167-72. PubMed ID: 15364100
[TBL] [Abstract][Full Text] [Related]
10. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections.
Naidu SS; Erdei J; Czirók E; Kalfas S; Gadó I; Thorén A; Forsgren A; Naidu AS
APMIS; 1991 Dec; 99(12):1142-50. PubMed ID: 1772651
[TBL] [Abstract][Full Text] [Related]
11. Bovine lactoferrin improves bone status of ovariectomized mice via immune function modulation.
Malet A; Bournaud E; Lan A; Mikogami T; Tomé D; Blais A
Bone; 2011 May; 48(5):1028-35. PubMed ID: 21303707
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha levels in mice subjected to surgery.
Zimecki M; Właszczyk A; Zagulski T; Kübler A
Arch Immunol Ther Exp (Warsz); 1998; 46(2):97-104. PubMed ID: 9613707
[TBL] [Abstract][Full Text] [Related]
13. Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues.
Fischer R; Debbabi H; Blais A; Dubarry M; Rautureau M; Boyaka PN; Tome D
Int Immunopharmacol; 2007 Oct; 7(10):1387-93. PubMed ID: 17673154
[TBL] [Abstract][Full Text] [Related]
14. Oral bovine lactoferrin improves bone status of ovariectomized mice.
Blais A; Malet A; Mikogami T; Martin-Rouas C; Tomé D
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1281-8. PubMed ID: 19336659
[TBL] [Abstract][Full Text] [Related]
15. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.
Håversen LA; Engberg I; Baltzer L; Dolphin G; Hanson LA; Mattsby-Baltzer I
Infect Immun; 2000 Oct; 68(10):5816-23. PubMed ID: 10992490
[TBL] [Abstract][Full Text] [Related]
16. Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine.
Iigo M; Alexander DB; Long N; Xu J; Fukamachi K; Futakuchi M; Takase M; Tsuda H
Biochimie; 2009 Jan; 91(1):86-101. PubMed ID: 18634843
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the activity of novobiocin against Escherichia coli by lactoferrin.
Sanchez MS; Watts JL
J Dairy Sci; 1999 Mar; 82(3):494-9. PubMed ID: 10194666
[TBL] [Abstract][Full Text] [Related]
18. [Effect of orally administered bovine lactoferrin and bovine IgG on the establishment of Escherichia coli in the digestive tract of gnotobiotic mice and human newborn infants].
Moreau MC; Duval-Iflah Y; Muller MC; Raibaud P; Vial M; Gabilan JC; Daniel N
Ann Microbiol (Paris); 1983; 134B(3):429-41. PubMed ID: 6372577
[TBL] [Abstract][Full Text] [Related]
19. Twenty-five years of research on bovine lactoferrin applications.
Tomita M; Wakabayashi H; Shin K; Yamauchi K; Yaeshima T; Iwatsuki K
Biochimie; 2009 Jan; 91(1):52-7. PubMed ID: 18585434
[TBL] [Abstract][Full Text] [Related]
20. Bovine lactoferrin protects lipopolysaccharide-induced diarrhea modulating nitric oxide and prostaglandin E2 in mice.
Talukder MJ; Harada E
Can J Physiol Pharmacol; 2007 Feb; 85(2):200-8. PubMed ID: 17487261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
